Abstract
For PET studies of benzodiazepine receptors, N-11C-methyl-2′-iododiazepam (2′-IDZ) was synthesized by N-methylation of its desmethyl derivative with11C-methyl iodide, and was subsequently purified by HPLC. The labeling and purification procedures were completed within 45 min after11C-methyl iodide trapping, and the radiochemical yield (corrected for decay) was approximately 40% based on the initial trapped radioactivity of11C-methyl iodide. Biodistribution studies in mice demonstrated that11C-2′-IDZ was rapidly and noticeably accumulated in the brain, and subsequently decreased with time. Accumulation was greater in the cortex than in other brain regions. When compared with125I-2′-IDZ, the distribution was almost the same until 5 min after injection, but levels were low after 20 min. Metabolic studies indicated that the difference between these two compounds in the time course of brain radioactivity distribution may be due to N-demethylationin vivo.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Savic I, Roland P, Sedvall G, Persson A, Pauli S, Widen L.In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci.Lancet II: 863–866, 1988.
Bartenstein P, Ludolph A, Schober O, Lottes G, Scheidhauer K, Sciuk J, et al. Benzodiazepine receptors and cerebral blood flow in partial epilepsy.Eur J Nucl Med 18: 111–118, 1991.
Whitehouse PJ, Trifiletti RR, Jones BE, Folstein S, Price DL, Snyder SH, et al. Neurotransmitter receptor alterations in Huntington’s disease: autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes.Ann Neurol 18: 202–210, 1985.
Trifiletti RR, Snowman AM, Whitehouse PJ, Marcus KA, Snyder SH. Huntington’s disease: increased number and altered regulation of benzodiazepine receptor complexes in frontal cerebral cortex.Neurology 37: 916–922, 1987.
Owen F, Poulter M, Waddington JL, Mashal RD, Crow TJ. [H-3]Ro 05-4864 and [H-3]flunitrazepam binding inkanate-lesioned rat striatum and in temporal cortex of brains from patients with senile dementia of Alzheimer type.Brain Res 278: 373–375, 1983.
Shinotoh H, Yamasaki T, Inoue O, Itoh T, Suzuki K, Hashimoto K, et al. Visualization of specific binding sites of benzodiazepine in human brain.J Nucl Med 27: 1593–1599, 1986.
Ishiwata K, Yanai K, Ido T, Miura-Kanno Y, Kawashima K. Synthesis and biodistribution of [11C]fludiazepam for imaging benzodiazepine receptors.Nucl Med Biol 15: 365–371, 1988.
Beer H-F, Blauenstein PA, Hasler PH, Delaloye B, Riccabona G, Bangerl I, et al.In vitro andin vivo evaluation of iodine-123-Ro 16-0154: a new imaging agent for SPECT investigations of benzodiazepine receptors.J Nucl Med 31: 1007–1014, 1990.
Sadzot B, Frost JJ. Benzodiazepine receptors.In Quantitative Imaging: Neuroreceptors, Neurotransmitters, and Enzymes, Frost JJ, Wagner Jr HN (eds.), New York, Raven Press, pp. 109–127, 1990.
Wilson AA, Dannals RF, Ravert HT, Wagner Jr HN. Preparation of [11C]- and [125I]IMB: a dopamine D-2 receptor antagonist.Appl Radiat Isot 40: 369–373, 1989.
Van Dort ME, Kilbourn MR, Chakraborty PK, Richfield EK, Gildersleeve DL, Wieland DM. Iodine-125 and fiuorine- 18 labeled aryl-1,4-dialkylpiperazines: potential radiopharmaceuticals forin vivo study of the dopamine uptake system.Appl Radiat Isot 43: 671–680, 1992.
Wong DF, Wilson AA, Chen C, Minkin E, Dannals RF, Ravert HT, et al.In-vivo studies of [I-125]idodbenzamide and [C-11]iodobenzamide—a ligand suitable for positron emission tomography and single photon emission tomography imaging of cerebral D(2)-dopamine receptors.Synapse 12: 236–241, 1992.
Kilbourn MR, Zalutsky MR. Research and clinical potential of receptor based radiophannaceuticals.J Nucl Med 26: 655–662, 1985.
Arnett CD, Shiue CY, Wolf AP, Fowler JS, Logan J, Watanabe M. Comparison of three18F-labeled butyrophenone neuroleptic drugs in the baboon using positron emission tomography.J Neurochem 44: 835–844, 1985.
Kung HF. Radiopharmaceuticals for CNS receptor imaging with SPECT.Nucl Med Biol 17: 85–92, 1990.
Van Der Kleijn E. Kinetics of distribution and metabolism of diazepam and chlordiazepoxide in mice.Arch Int Pharmacodyn 178: 193–215, 1969.
Sternbach LH, Randall LO, Banziger R, Lehr H. Structureactivity relationships in the 1,4-benzodiazepine series.In Drugs Affecting The Central Nervous System, Volume 2, Burger A (ed.), New York, Mercel Dekker Inc., pp. 237–264, 1968.
Boera PA, Gilli G, Bertolasi V. Application of the Free-Wilson model to the analysis of three different pharmacological activity tests in benzodiazepines.Farmaco-Ed Sc 34: 1073–1082, 1979.
Haefely W, Kyburz E, Gerecke M, Mohler H. Recent advances in the molecular pharmacology of benzodiazepine receptors and in the structure-activity relationships of their agonists and antagonists.In Advances in Drug Research, Volume 14, Testa B (ed.), London, Academic Press Inc., pp. 165–322, 1985.
Gupta SP, Saha RN, Muichandani V. Quantitative structure-activity relationship studies on benzodiazepine receptor binding: recognition of active sites in receptor and modelling of interaction.J Mol Recognit 5: 75–80, 1992.
Saji H, Iida Y, Ariyoshi K, Nakatsuka I, Kataoka M, Yoshitake A, et al. An approach for benzodiazepine receptor binding assay with radioiodinated ligand:125I-labeled diazepam derivative.Biol Pharm Bull 16: 513–515, 1993.
Saji H, Iida Y, Nakatsuka I, Kataoka M, Ariyoshi K, Magata Y, et al. Radioiodinated 2’-iododiazepam: apotential imaging agent for SPECT investigations of benzodiazepine receptors.J Nucl Med 34: 932–937, 1993.
Saji H, Magata Y, Yamada Y, Tajima K, Yomekura Y, Konishi J, et al. Synthesis of (S)-N-[methyl-11C]nicotine and its regional distribution in the mouse brain: a potential tracer for visualization of brain nicotinic receptors by positron emission tomography.Chem Pharm Bull 40: 734–736, 1992.
Glowinski J, Iversen L. Regional studies of catecholamines in the rat brain-I: the disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions on the brain.J Neurochem 13: 655–669, 1966.
Comar D, Maziere M, Cepeda C, Godot J-M, Menini C, Naquet R. The kinetics and displacement of [11C]flunitrazepam in the brain of the living baboon.Eur J Pharmacol 75: 21–26, 1981.
Kaplan SA, Jack ML. Metabolism of the benzodiazepines: pharmacokinetic and pharmacodynamic considerations.In The Bezodiazepines: From Molecular Biology to Clinical Practice, Costa E (ed.), New York, Raven Press, pp. 173–199, 1983.
Xie X, Steiner H, Bickel MH. Kinetics of distribution and adipose tissue storage as a function of lipophilicity and chemical structure.Drug Metab Disposition 19: 15–19, 1991.
Richelson E, Nelson A, Neeper R. Binding of benzodiazepines and some major metabolites at their sites in normal human frontal cortexin vitro.J Pharmacol Exp Ther 256: 897–901, 1991.
Schwartz MA, Postma E. Metabolism of diazepamin vitro.Biochem Pharmacol 17: 2443–2449, 1968.
Saji H, Iida Y, Nakatsuka I, Kataoka M, Yoshitake A, Yokoyama A. Evaluation of radioiodinated desmethyl diazepam as radiotracer forin vivo quantitative studies of benzodiazepine receptors.J Labelled Compd Radiopharm 32: 340–341, 1993.
Richard JG, Mohler H. Benzodiazepine receptors.Neuropharmacology 23: 233–242, 1984.
Samson Y. Hantraye P, Baron JC, Soussaline F, Comar D, Maziere M. Kinetics and displacement of [C-11]Ro 15-1788, a benzodiazepine antagonist, studies in human brainin vivo by positron tomography.Eur J Pharmacol 110: 247–251, 1985.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Iida, Y., Saji, H., Magata, Y. et al. 11C-labeled 2′-iododiazepam for PET studies of benzodiazepine receptors: Synthesis and comparison of biodistribution with its radioiodinated compound. Ann Nucl Med 8, 17–22 (1994). https://doi.org/10.1007/BF03164982
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03164982